🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study tests a new medication for treatment of kidney cancer, called BE...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-10
Trial ID
NCT01453595
Treatments Being Tested
It is known that after application of MK-3475 activated PD -1 negatively re...
Status
Unknown
Location
Dana-Farber Cancer Institute
Start Date
2013-03
Trial ID
NCT02430363
Treatments Being Tested
The purpose of this study is to determine if prophylaxis with RTB101 decrea...
Status
Terminated
Location
Nursing Home
Start Date
2020-07-11
Trial ID
NCT04409327
This is an open-label phase Ib multi-institution trial that evaluates the s...
Status
Completed
Location
University of Alabama
Start Date
2010-11
Trial ID
NCT01248494
Study has two parts: 1. Dose-finding: to determine the maximum tolerated d...
Status
Completed
Location
Highlands Oncology Group Dept of Highlands Oncology Grp
Start Date
2012-01
Trial ID
NCT01482156
Treatments Being Tested
This is a prospective, multi-center, open-label, phase Ib/ II study (two pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01471847
Treatments Being Tested
Study objectives: The primary objective is to determine the efficacy of BE...
Status
Withdrawn
Location
Novartis Investigative Site
Start Date
2012-09
Trial ID
NCT01690871
Treatments Being Tested
This is a Phase II study in 2 stages, evaluating BEZ235 plus best supportiv...
Status
Completed
Location
Indiana University SC
Start Date
2012-11
Trial ID
NCT01658436
Treatments Being Tested
The mTOR (mammalian Target of Rapamycin) protein is the center of the mTOR ...
Status
Terminated
Location
Clinique Saint-Pierre à Ottignies
Start Date
2013-02
Trial ID
NCT01856101
Treatments Being Tested